Literature DB >> 44038

The Rift Valley fever epizootic in Egypt 1977-78. 2. Ecological and entomological studies.

H Hoogstraal, J M Meegan, G M Khalil, F K Adham.   

Abstract

Epidemiological factors related to the introduction, spread and maintenance of Rift Valley fever (RVF) virus were studied during the 1977-78 epizootic in Egypt, Culex pipiens is the most ubiquitous and prevalent mosquito species in the Nile Valley and Delta. Isolation of RVF virus from unengorged C. pipiens, and demonstration of laboratory transmission of the virus by this species, strongly implicate it as the chief vector in Egypt. Virus transmission to man also occurs by contamination when handling infected meat and by inhaling natural virus aerosols. Wild rodents apparently do not serve as RVF virus reservoirs. Domestic sheep, cattle, buffaloes, camels, goats, donkeys and dogs act as amplifying hosts. Over 30% of the camels sampled at the southern border of Egypt were serologically positive for antibodies to RVF virus and it appears likely that the virus was introduced into Egypt, either by these animals or by other vehicles from the south.

Entities:  

Mesh:

Year:  1979        PMID: 44038     DOI: 10.1016/0035-9203(79)90005-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  56 in total

1.  Ngari virus is a Bunyamwera virus reassortant that can be associated with large outbreaks of hemorrhagic fever in Africa.

Authors:  Sonja R Gerrard; Li Li; Alan D Barrett; Stuart T Nichol
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 2.  Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus.

Authors:  Clayton A Wiley; Nitin Bhardwaj; Ted M Ross; Stephanie J Bissel
Journal:  Brain Pathol       Date:  2015-09       Impact factor: 6.508

3.  Evolutionary history of a mosquito endosymbiont revealed through mitochondrial hitchhiking.

Authors:  Jason L Rasgon; Anthony J Cornel; Thomas W Scott
Journal:  Proc Biol Sci       Date:  2006-07-07       Impact factor: 5.349

4.  Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus.

Authors:  K Keegan; M S Collett
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

Review 5.  Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.

Authors:  Colm Atkins; Alexander N Freiberg
Journal:  Future Virol       Date:  2017-10-23       Impact factor: 1.831

Review 6.  A review of mosquitoes associated with Rift Valley fever virus in Madagascar.

Authors:  Luciano M Tantely; Sébastien Boyer; Didier Fontenille
Journal:  Am J Trop Med Hyg       Date:  2015-03-02       Impact factor: 2.345

7.  A statistical model of Rift Valley fever activity in Egypt.

Authors:  John M Drake; Ali N Hassan; John C Beier
Journal:  J Vector Ecol       Date:  2013-12       Impact factor: 1.671

8.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

9.  Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.

Authors:  Elizabeth R Wonderlich; Amy L Caroline; Cynthia M McMillen; Aaron W Walters; Douglas S Reed; Simon M Barratt-Boyes; Amy L Hartman
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

10.  Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.

Authors:  Tetsuro Ikegami; Krishna Narayanan; Sungyong Won; Wataru Kamitani; C J Peters; Shinji Makino
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.